Adding to the complexity, AR expression is prognostic of both improved and worse patient outcomes depending on protein vs. mRNA detection platforms, discrepancies in binning of expression levels, breast cancer subtype, and clinical endpoints (reviewed in [122,124]). Here, AR is linked to breast carcinoma.